Serial Measurement of Galectin-3 in Patients with Chronic Heart Failure: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study - Concepedia

Concepedia

Publication | Closed Access

Serial Measurement of Galectin-3 in Patients with Chronic Heart Failure: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study

118

Citations

14

References

2013

Year

Shweta R. Motiwala, Jackie Szymonifka, Arianna M. Belcher, Rory B. Weiner, Aaron L. Baggish, Patrick M. Sluss, Hanna K. Gaggin, Anju Bhardwaj, James L. Januzzi

European Journal of Heart Failure

Abstract

In chronic HF due to LVSD, serial galectin-3 measurement adds incremental prognostic information and predicts LV remodelling. In this study, HF therapies had no clear effects on galectin-3 levels.

References

	Year	Citations

Page 1